← Back to headlines
RBC Capital Cuts Price Target on Nuvation Bio
RBC Capital has reduced its price target for Nuvation Bio (NUVB) in its Q2 preview, indicating a revised outlook for the biotechnology company.
15 Jul, 08:32 — 15 Jul, 08:32
Sources
Showing 1 of 1 sources
